Vaxart, Inc.
VXRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 82.3% | 90.3% | 37.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.5% | -30.4% | -58.7% | -57% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.2% | -37.7% | -74.7% | -78.9% |
| EPS Diluted | -0.04 | -0.07 | -0.068 | -0.053 |
| % Growth | 42.9% | -2.3% | -30% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |